FI970892A0 - Ilmentymiseltään kohdennetut retrovirusvektorit, jotka eivät ole itsestään inaktivoivia - Google Patents

Ilmentymiseltään kohdennetut retrovirusvektorit, jotka eivät ole itsestään inaktivoivia

Info

Publication number
FI970892A0
FI970892A0 FI970892A FI970892A FI970892A0 FI 970892 A0 FI970892 A0 FI 970892A0 FI 970892 A FI970892 A FI 970892A FI 970892 A FI970892 A FI 970892A FI 970892 A0 FI970892 A0 FI 970892A0
Authority
FI
Finland
Prior art keywords
region
inactivating
expressed
self
retroviral vectors
Prior art date
Application number
FI970892A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970892L (fi
FI970892A7 (fi
Inventor
Walter Henry Guenzburg
Robert Michael Saller
Original Assignee
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsf Forschungszentrum Umwelt filed Critical Gsf Forschungszentrum Umwelt
Publication of FI970892L publication Critical patent/FI970892L/fi
Publication of FI970892A7 publication Critical patent/FI970892A7/fi
Publication of FI970892A0 publication Critical patent/FI970892A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Ceramic Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Traffic Control Systems (AREA)
  • Navigation (AREA)
  • Molds, Cores, And Manufacturing Methods Thereof (AREA)
  • Road Signs Or Road Markings (AREA)
  • Optical Radar Systems And Details Thereof (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
FI970892A 1994-09-02 1995-09-01 Ilmentymiseltään kohdennetut retrovirusvektorit, jotka eivät ole itsestään inaktivoivia FI970892A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK101794 1994-09-02
PCT/EP1995/003445 WO1996007748A1 (en) 1994-09-02 1995-09-01 Non self-inactivating, expression targeted retroviral vectors

Publications (3)

Publication Number Publication Date
FI970892L FI970892L (fi) 1997-02-28
FI970892A7 FI970892A7 (fi) 1997-02-28
FI970892A0 true FI970892A0 (fi) 1997-02-28

Family

ID=8100062

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970892A FI970892A0 (fi) 1994-09-02 1995-09-01 Ilmentymiseltään kohdennetut retrovirusvektorit, jotka eivät ole itsestään inaktivoivia

Country Status (20)

Country Link
US (1) US7531353B1 (pl)
EP (1) EP0779929B1 (pl)
JP (1) JP4037446B2 (pl)
CN (1) CN1117156C (pl)
AT (1) ATE200517T1 (pl)
AU (1) AU688590B2 (pl)
BR (1) BR9508664A (pl)
CA (1) CA2198210C (pl)
DE (1) DE69520681T2 (pl)
DK (1) DK0779929T5 (pl)
EE (1) EE03492B1 (pl)
ES (1) ES2156945T3 (pl)
FI (1) FI970892A0 (pl)
HU (1) HU221607B (pl)
MX (1) MX9701544A (pl)
NO (1) NO317731B1 (pl)
NZ (1) NZ292897A (pl)
PL (1) PL184375B1 (pl)
RU (1) RU2199585C2 (pl)
WO (1) WO1996007748A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9701544A (es) 1994-09-02 1998-03-31 Gsf Forschungszentrum Umwelt Vectores de expresion retrovirales dirigidos, no autoinactivantes.
ATE238427T1 (de) * 1995-03-09 2003-05-15 Austrian Nordic Biotherapeutic Vektoren, die therapeutische gene fuer antimikrobielle peptide enthalten, zur verwendung in der gentherapie
WO1997001357A1 (en) 1995-06-27 1997-01-16 Bavarian Nordic Research Institute A/S Encapsulated cells producing viral particles
US7074398B1 (en) 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences
AU7291696A (en) * 1995-10-13 1997-04-30 Bavarian Nordic Research Institute A/S Retroviral vectors carrying senescent cell derived inhibitors 1 (sdi-1) or antisense sdi-1 nucleotide sequences
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
IL125795A0 (en) 1996-03-27 1999-04-11 Bavarian Nordic Res Inst As Retroviral vectors encoding a cytochrome p450 gene
EP0961830A1 (en) * 1997-01-29 1999-12-08 Neurosearch A/S EXPRESSION VECTORS AND METHODS FOR $i(IN VIVO) EXPRESSION OF THERAPEUTIC POLYPEPTIDES
ES2373406T3 (es) * 1997-12-22 2012-02-03 Oxford Biomedica (Uk) Limited Vectores basados en el virus de la anemia infecciosa equina (vaie).
ATE278029T1 (de) 1998-01-06 2004-10-15 Inst Virologie Teilrechtsfaehi Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression
FR2778670B1 (fr) * 1998-05-18 2002-12-13 Rhone Poulenc Rorer Sa Methodes et compositions pour la production de particules virales
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
WO2000066758A1 (en) * 1999-04-29 2000-11-09 Aarhus University Expression of heterologous genes from an ires translational cassette in retroviral vectors
WO2002064805A2 (en) * 2001-02-09 2002-08-22 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Replication competent non-mammalian retroviral vectors
DE102009021592A1 (de) * 2009-05-15 2010-11-18 Medizinische Hochschule Hannover ASLV-Vektorsystem
CN120866241B (zh) * 2025-09-28 2026-01-30 深圳细胞谷生物医药有限公司 通过稳定细胞系生产工程化类病毒颗粒的方法及其工程化类病毒颗粒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02504344A (ja) 1988-05-17 1990-12-13 スローン‐ケツテリング・インステイテユート・フオー・キヤンサー・リサーチ レトロウイルスベクター
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
WO1994029437A1 (en) * 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
MX9701544A (es) 1994-09-02 1998-03-31 Gsf Forschungszentrum Umwelt Vectores de expresion retrovirales dirigidos, no autoinactivantes.
ATE238427T1 (de) * 1995-03-09 2003-05-15 Austrian Nordic Biotherapeutic Vektoren, die therapeutische gene fuer antimikrobielle peptide enthalten, zur verwendung in der gentherapie
JPH11508441A (ja) * 1995-03-09 1999-07-27 ババリアン・ノルディック・リサーチ・インスティテュート・アクティーゼルスカブ 遺伝子治療用の新規組換えｄｎａベクター
US6117681A (en) * 1995-03-29 2000-09-12 Bavarian Nordic Research Inst. A/S Pseudotyped retroviral particles
GB9510272D0 (en) 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors
US7074398B1 (en) * 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences

Also Published As

Publication number Publication date
EE9700040A (et) 1997-08-15
FI970892L (fi) 1997-02-28
NO970902D0 (no) 1997-02-27
CN1117156C (zh) 2003-08-06
PL184375B1 (pl) 2002-10-31
NO317731B1 (no) 2004-12-13
RU2199585C2 (ru) 2003-02-27
HK1001527A1 (en) 1998-06-26
DE69520681T2 (de) 2001-11-29
DK0779929T5 (da) 2001-08-13
JP4037446B2 (ja) 2008-01-23
JPH10507628A (ja) 1998-07-28
CA2198210A1 (en) 1996-03-14
HU221607B (hu) 2002-11-28
US7531353B1 (en) 2009-05-12
EE03492B1 (et) 2001-08-15
CN1159210A (zh) 1997-09-10
ATE200517T1 (de) 2001-04-15
AU688590B2 (en) 1998-03-12
DE69520681D1 (de) 2001-05-17
EP0779929B1 (en) 2001-04-11
NZ292897A (en) 1998-08-26
BR9508664A (pt) 1998-01-06
NO970902L (no) 1997-04-24
EP0779929A1 (en) 1997-06-25
DK0779929T3 (da) 2001-05-07
AU3520195A (en) 1996-03-27
FI970892A7 (fi) 1997-02-28
CA2198210C (en) 2006-07-11
PL319033A1 (en) 1997-07-21
WO1996007748A1 (en) 1996-03-14
MX9701544A (es) 1998-03-31
ES2156945T3 (es) 2001-08-01
HUT76974A (hu) 1998-01-28

Similar Documents

Publication Publication Date Title
FI970892A0 (fi) Ilmentymiseltään kohdennetut retrovirusvektorit, jotka eivät ole itsestään inaktivoivia
WO1998039463A3 (en) Lentivirus based vector and vector system
EE04378B1 (xx) LAG-3 pleissimisteisendid
ATE250629T1 (de) Für säugetierphosphodiesterasen kodierende dns
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
DK0630409T3 (da) Defekt-pakkende ikke-onkovirus-vektorer baseret på MPMV
DK2256205T3 (da) Porphorymonas gingivalis-polypeptider og -polynukleotider
BR9407693A (pt) Sequência nucleotídica vetor composiçao farmacêutica utilizaçao do vetor e de um composto
ATE173762T1 (de) Klonierung der n-methylhydantoinase
DE69321235D1 (de) Promoter vom k. lactis pyruvat-decarboxylase gen und anwendung davon
CA2429451A1 (en) Isolated luciferases and their use
ID20153A (id) Proses polimerisasi etilena dengan adanya suatu katalis kromium oksida
DE59710850D1 (de) Lagerstabile, feuchtigkeitshärtende Klebstoffmasse
ATE278029T1 (de) Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression
ES8505684A1 (es) Procedimiento para preparar (1, 2, 4) triazol (1, 5-c)pirimidin-2-aminas 5-sustituidas
DE69418050D1 (de) Antivirale analoge von difluorostaton
DE69534246D1 (de) Mn-gen und -protein
UA20042A (uk) Біс-n,n-диметил-n-(2-гідрокси-3-бутоксипропіл) аміhо-ізо-фталімід як латеhтhий каталізатор отвердіhhя епоксидhих композицій
UA20041A (uk) Біс-n,n-диметил-n-(2-гідрокси-3-бутоксипропіл) аміhоадипоілімід як латеhтhий каталізатор отвердіhhя епоксидhих композицій
IT1277706B1 (it) Catalizzatore zeolitico per la sintesi di cumene e procedimento per la preparazione di cumene impiegando il medesimo